macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87: 4828–4832. 5. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442–444. 6. Dai XM, Zong XH, Sylvestre V, Stanley ER (2004) Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood 103: 1114–1123. 7. Wei S, Lightwood D, Ladyman H, Cross S, Neale H, et al. (2005) Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. Immunobi- ology 210: 109–119. 8. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, et al. (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178: 1733–1744. 9. Edwards M, Sarma U, Flanagan AM (1998) Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones. Bone 22: 325–329. 10. Sarma U, Flanagan AM (1996) Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 88: 2531–2540. 11. Hodge JM, Kirkland MA, Nicholson GC (2007) Multiple roles of M-CSF in human osteoclastogenesis. J Cell Biochem 102: 759–768. 12. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423: 337–342. 13. Bradley EW, Oursler MJ (2008) Osteoclast culture and resorption assays. Methods Mol Biol 455: 19–35. 14. Bruzzaniti A, Baron R (2006) Molecular regulation of osteoclast activity. Rev Endocr Metab Disord 7: 123–139. 15. Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA (2006) RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. Bone 38: 678–685. 16. Lee SK, Lorenzo J (2006) Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 18: 411–418. 17. Fuller K, Kirstein B, Chambers TJ (2006) Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147: 1979–1985. 18. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA (1987) Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin- stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 121: 1164–1170. 19. Hodge JM, Kirkland MA, Aitken CJ, Waugh CM, Myers DE, et al. (2004) Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF. J Bone Miner Res 19: 190–199. 20. Pavlos NJ, Xu J, Riedel D, Yeoh JS, Teitelbaum SL, et al. (2005) Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol 25: 5253–5269. 21. Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, et al. (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond) 99: 133–140. 22. Dey A, She H, Kim L, Boruch A, Guris DL, et al. (2000) Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell 11: 3835–3848. 23. Holmes SG, Still K, Buttle DJ, Bishop NJ, Grabowski PS (2004) Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone 35: 471–478. M-CSF Augments Resorption by Human Osteoclasts 24. Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, et al. (2000) Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol 148: 333–342. 25. Cano E, Mahadevan LC (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20: 117–122. 26. Lee ZH, Kim HH (2003) Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305: 211–214. 27. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165–176. 28. Lakkakorpi PT, Vaananen HK (1991) Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J Bone Miner Res 6: 817–826. 29. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188: 997–1001. 30. Myers DE, Collier FM, Minkin C, Wang H, Holloway WR, et al. (1999) Expression of functional RANK on mature rat and human osteoclasts. FEBS Lett 463: 295–300. 31. Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC, et al. (2004) Src kinase activity is essential for osteoclast function. J Biol Chem 279: 17660–17666. 32. Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693–702. 33. Grey A, Chen Y, Paliwal I, Carlberg K, Insogna K (2000) Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141: 2129–2138. 34. Bradley EW, Ruan MM, Vrable A, Oursler MJ (2008) Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK- mediated osteoclast survival. J Cell Biochem 104: 1439–1451. 35. Yao GQ, Itokawa T, Paliwal I, Insogna K (2005) CSF-1 induces fos gene transcription and activates the transcription factor Elk-1 in mature osteoclasts. Calcif Tissue Int 76: 371–378. 36. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, et al. (1994) c- Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443–448. 37. Owens JM, Matsuo K, Nicholson GC, Wagner EF, Chambers TJ (1999) Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J Cell Physiol 179: 170–178. 38. Ryan GR, Dai XM, Dominguez MG, Tong W, Chuan F, et al. (2001) Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 98: 74–84. 39. Suehiro A, Imagawa T, Hosokawa H, Suehiro M, Ohe Y, et al. (1999) Age related elevation of serum macrophage colony stimulating factor (M-CSF) level. Arch Gerontol Geriatr 29: 13–20. 40. Desai MP, Bhanuprakash KV, Khatkhatay MI, Donde UM (2007) Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Anal 21: 55–60. 41. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K (2007) Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22: 487–494. 42. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ (2008) Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 105: 20764–20769. PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e21462